Literature DB >> 23787162

Transmission scenarios for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) and how to tell them apart.

S Cauchemez1, M D Van Kerkhove, S Riley, C A Donnelly, C Fraser, N M Ferguson.   

Abstract

Detection of human cases of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection internationally is a global public health concern. Rigorous risk assessment is particularly challenging in a context where surveillance may be subject to under-ascertainment and a selection bias towards more severe cases. We would like to assess whether the virus is capable of causing widespread human epidemics, and whether self-sustaining transmission is already under way. Here we review possible transmission scenarios for MERS-CoV and their implications for risk assessment and control. We discuss how existing data, future investigations and analyses may help in reducing uncertainty and refining the public health risk assessment and present analytical approaches that allow robust assessment of epidemiological characteristics, even from partial and biased surveillance data. Finally, we urge that adequate data be collected on future cases to permit rigorous assessment of the transmission characteristics and severity of MERS-CoV, and the public health threat it may pose. Going beyond minimal case reporting, open international collaboration, under the guidance of the World Health Organization and the International Health Regulations, will impact on how this potential epidemic unfolds and prospects for control.

Entities:  

Mesh:

Year:  2013        PMID: 23787162      PMCID: PMC4088931     

Source DB:  PubMed          Journal:  Euro Surveill        ISSN: 1025-496X


  22 in total

1.  Novel coronavirus infections in Jordan, April 2012: epidemiological findings from a retrospective investigation.

Authors:  B Hijawi; M Abdallat; A Sayaydeh; S Alqasrawi; A Haddadin; N Jaarour; S Alsheikh; T Alsanouri
Journal:  East Mediterr Health J       Date:  2013       Impact factor: 1.628

2.  Saudi Arabia and the emergence of a novel coronavirus.

Authors:  Z A Memish; R Alhakeem; G M Stephens
Journal:  East Mediterr Health J       Date:  2013       Impact factor: 1.628

3.  Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia.

Authors:  Ali M Zaki; Sander van Boheemen; Theo M Bestebroer; Albert D M E Osterhaus; Ron A M Fouchier
Journal:  N Engl J Med       Date:  2012-10-17       Impact factor: 91.245

4.  Evidence of person-to-person transmission within a family cluster of novel coronavirus infections, United Kingdom, February 2013.

Authors: 
Journal:  Euro Surveill       Date:  2013-03-14

5.  Epidemiological characteristics of 2009 (H1N1) pandemic influenza based on paired sera from a longitudinal community cohort study.

Authors:  Steven Riley; Kin O Kwok; Kendra M Wu; Danny Y Ning; Benjamin J Cowling; Joseph T Wu; Lai-Ming Ho; Thomas Tsang; Su-Vui Lo; Daniel K W Chu; Edward S K Ma; J S Malik Peiris
Journal:  PLoS Med       Date:  2011-06-21       Impact factor: 11.069

6.  Superspreading and the effect of individual variation on disease emergence.

Authors:  J O Lloyd-Smith; S J Schreiber; P E Kopp; W M Getz
Journal:  Nature       Date:  2005-11-17       Impact factor: 49.962

7.  The consortium for the standardization of influenza seroepidemiology (CONSISE): a global partnership to standardize influenza seroepidemiology and develop influenza investigation protocols to inform public health policy.

Authors:  Maria D Van Kerkhove; Eeva Broberg; Othmar G Engelhardt; John Wood; Angus Nicoll
Journal:  Influenza Other Respir Viruses       Date:  2012-12-26       Impact factor: 4.380

8.  Clinical features and viral diagnosis of two cases of infection with Middle East Respiratory Syndrome coronavirus: a report of nosocomial transmission.

Authors:  Benoit Guery; Julien Poissy; Loubna el Mansouf; Caroline Séjourné; Nicolas Ettahar; Xavier Lemaire; Fanny Vuotto; Anne Goffard; Sylvie Behillil; Vincent Enouf; Valérie Caro; Alexandra Mailles; Didier Che; Jean-Claude Manuguerra; Daniel Mathieu; Arnaud Fontanet; Sylvie van der Werf
Journal:  Lancet       Date:  2013-05-30       Impact factor: 79.321

9.  The SARS epidemic in mainland China: bringing together all epidemiological data.

Authors:  Dan Feng; Sake J de Vlas; Li-Qun Fang; Xiao-Na Han; Wen-Juan Zhao; Shen Sheng; Hong Yang; Zhong-Wei Jia; Jan Hendrik Richardus; Wu-Chun Cao
Journal:  Trop Med Int Health       Date:  2009-06-05       Impact factor: 2.622

10.  Applying lessons from SARS to a newly identified coronavirus.

Authors:  Brian McCloskey; Alimuddin Zumla; Gwen Stephens; David L Heymann; Ziad A Memish
Journal:  Lancet Infect Dis       Date:  2013-03-21       Impact factor: 25.071

View more
  59 in total

1.  Preliminary epidemiological assessment of MERS-CoV outbreak in South Korea, May to June 2015.

Authors:  B J Cowling; M Park; V J Fang; P Wu; G M Leung; J T Wu
Journal:  Euro Surveill       Date:  2015-06-25

2.  A conformation-dependent neutralizing monoclonal antibody specifically targeting receptor-binding domain in Middle East respiratory syndrome coronavirus spike protein.

Authors:  Lanying Du; Guangyu Zhao; Yang Yang; Hongjie Qiu; Lili Wang; Zhihua Kou; Xinrong Tao; Hong Yu; Shihui Sun; Chien-Te K Tseng; Shibo Jiang; Fang Li; Yusen Zhou
Journal:  J Virol       Date:  2014-04-09       Impact factor: 5.103

3.  One-Health: a Safe, Efficient, Dual-Use Vaccine for Humans and Animals against Middle East Respiratory Syndrome Coronavirus and Rabies Virus.

Authors:  Christoph Wirblich; Christopher M Coleman; Drishya Kurup; Tara S Abraham; John G Bernbaum; Peter B Jahrling; Lisa E Hensley; Reed F Johnson; Matthew B Frieman; Matthias J Schnell
Journal:  J Virol       Date:  2017-01-03       Impact factor: 5.103

4.  Post-Covid-19 Rhino-Cerebral Mucormycosis: an Observational Study During the Second Wave.

Authors:  Anandkumar Sajjan; Anand V Nimbal; Roopa Shahapur; Ishwar B Bagoji; Vinutha A Chiniwar; Sreedevi K Chillalashetti
Journal:  Maedica (Bucur)       Date:  2022-03

5.  In vitro Anti SARS-CoV-2 Activity and Docking Analysis of Pleurotus ostreatus, Lentinula edodes and Agaricus bisporus Edible Mushrooms.

Authors:  Shaza M Elhusseiny; Taghrid S El-Mahdy; Nooran S Elleboudy; Ibrahim S Yahia; Mohamed M S Farag; Nasser S M Ismail; Mahmoud A Yassien; Khaled M Aboshanab
Journal:  Infect Drug Resist       Date:  2022-07-02       Impact factor: 4.177

6.  Distinguishing Between Reservoir Exposure and Human-to-Human Transmission for Emerging Pathogens Using Case Onset Data.

Authors:  Adam Kucharski; Harriet Mills; Amy Pinsent; Christophe Fraser; Maria Van Kerkhove; Christl A Donnelly; Steven Riley
Journal:  PLoS Curr       Date:  2014-03-07

Review 7.  Potential Biases in Estimating Absolute and Relative Case-Fatality Risks during Outbreaks.

Authors:  Marc Lipsitch; Christl A Donnelly; Christophe Fraser; Isobel M Blake; Anne Cori; Ilaria Dorigatti; Neil M Ferguson; Tini Garske; Harriet L Mills; Steven Riley; Maria D Van Kerkhove; Miguel A Hernán
Journal:  PLoS Negl Trop Dis       Date:  2015-07-16

Review 8.  SARS-CoV-2: Origin, Evolution, and Targeting Inhibition.

Authors:  Shuo Ning; Beiming Yu; Yanfeng Wang; Feng Wang
Journal:  Front Cell Infect Microbiol       Date:  2021-06-17       Impact factor: 5.293

9.  Ligand-induced Dimerization of Middle East Respiratory Syndrome (MERS) Coronavirus nsp5 Protease (3CLpro): IMPLICATIONS FOR nsp5 REGULATION AND THE DEVELOPMENT OF ANTIVIRALS.

Authors:  Sakshi Tomar; Melanie L Johnston; Sarah E St John; Heather L Osswald; Prasanth R Nyalapatla; Lake N Paul; Arun K Ghosh; Mark R Denison; Andrew D Mesecar
Journal:  J Biol Chem       Date:  2015-06-08       Impact factor: 5.157

10.  A truncated receptor-binding domain of MERS-CoV spike protein potently inhibits MERS-CoV infection and induces strong neutralizing antibody responses: implication for developing therapeutics and vaccines.

Authors:  Lanying Du; Zhihua Kou; Cuiqing Ma; Xinrong Tao; Lili Wang; Guangyu Zhao; Yaoqing Chen; Fei Yu; Chien-Te K Tseng; Yusen Zhou; Shibo Jiang
Journal:  PLoS One       Date:  2013-12-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.